Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jan 20;170(2):229-38.

Adverse effects of antiretroviral therapy for HIV infection

Affiliations
Review

Adverse effects of antiretroviral therapy for HIV infection

Valentina Montessori et al. CMAJ. .

Abstract

Long-term remission of HIV-1 disease can be readily achieved by combinations of antiretroviral agents. The suppression of plasma viral loads to less than the limit of quantification of the most sensitive commercially available assays (i.e., less than 50 copies/mL) and the coincident improvement in CD4 T cell counts is associated with resolution of established opportunistic infections and a decrease in the risk of new opportunistic infections. However, prolonged treatment with combination regimens can be difficult to sustain because of problems with adherence and toxic effects. All antiretroviral drugs can have both short-term and long-term adverse events. The risk of specific side effects varies from drug to drug, from drug class to drug class, and from patient to patient. A better understanding of the adverse effects of antiretroviral agents is of interest not only for HIV specialists as they try to optimize therapy, but also for other physicians who care for HIV-positive patients.

PubMed Disclaimer

Figures

None
Fig. 1: Adverse effects of antiretroviral therapy. In some cases, only a certain drug causes the effect (drug name in parentheses). Photo: Chesley Sheppard
Box 1
Box 1
None
Fig. 2: Postulated mechanism by which nucleoside reverse transcriptase inhibitor (NRTI) therapy interferes with glycolysis, leading to lactic acidosis. Dashed lines indicate steps occurring within the mitochondria, for which normal mitochondrial function is required. These steps are subject to impairment by NRTI therapy. If such impairment occurs, pyruvate and NADH accumulate, enhancing the conversion of pyruvate into lactate, which ultimately leads to lactic acidosis. AcetylCoA = acetylcoenzyme A, ATP = adenosine triphosphate, LDH = lactate dehydrogenase, NAD = nicotinamide adenine dinucleotide, NADH = reduced form of NAD.
None
Fig. 3: Clinical features of lipodystrophy. Top: Dorsocervical fat pad. Bottom: Central fat accumulation with abdominal skin striae and thinning of the extremities. Reproduced, with permission, from the Canadian Respiratory Journal.

References

    1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhre J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60. - PubMed
    1. Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. AIDS Cohort Study Investigators. JAMA 1998;280:1497-503. - PubMed
    1. Hogg RS, Yip B, Kully C, Craib KJP, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 1999;160(5):659-65. - PMC - PubMed
    1. d'Arminio Monforte A, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.C.O.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS 2000;14:499-507. - PubMed
    1. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131:81-7. - PubMed

MeSH terms

Substances